Enlightening Lab Med - The 6th IVD Youth Entrepreneur Forum (ELMY) is scheduled to be held at Primus Hotel Nanchang International Expo City on May 26 in 2023.
The forum will start from four key words: new track, new pursuit, new mission and new vision, show the innovation power, advanced technology, social responsibility, reform and inheritance of young entrepreneur to convey the voice of the new generation in the context of the new era.
The forum will bring together the chairmen of listed companies, experienced experts, investors, partners and other influencers in the in vitro diagnostic industry to build a communication platform for the young entrepreneurs group. We hope that the ELMY forum will help young entrepreneurs strengthen exchanges on industrial innovation and capacity enhancement, and contribute to the advancement of economic and social development.
We kindly welcome your participation to jointly promote the development and progress of the global IVD industry.
TIME (UTC+8)
08:30-12:00 | Friday, 26 May 2023
LOCATION
Primus Hotel Nanchang International Expo City
No.1100 Shangrao Street
Nanchang City, China
CONCURRENT ACTIVITIES IN 2023
• The 20th China Association of Clinical Laboratory Practice Expo (CACLP)
• The 3rd China IVD Supply Chain Expo (CISCE)
• The 10th China IVD Industry Development Conference (CIIDC)
• The 8th China Experimental Medicine Conference (CEMC)
• The 5th China IVD Distribution Enterprise Forum (CIDEF)
• The 3rd China Key Raw Material & Parts Forum (CKRMPF)
ORGANIZATION STRACTURE
• Honorary chairman: Quan JI, Changqing LIN
• Chairman: Kunhui HU
• Executive chairman: Zhisheng GUAN
ORGANIZER:
SUPPORTER:
Please following https://www.caivd-org.cn/en/ for more details.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.